SS Innovations International (SSII) Depreciation & Amortization (CF) (2017 - 2026)
SS Innovations International's (SSII) quarterly Depreciation & Amortization (CF) came in at $323747.0 in Q1 2026, up 54.99% year-on-year from $208882.0 in Q1 2025, and up 4.61% quarter-over-quarter from $309491.0 in Q4 2025.
SS Innovations International (SSII) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
SS Innovations International has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $323747.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $323747.0, up 54.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 110.84% YoY), and the FY2025 annual result was $1.1 million, up 146.76% from the prior year.
- Depreciation & Amortization (CF) came in at $323747.0 for Q1 2026 at SS Innovations International, up from $309491.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $323747.0 in Q1 2026 to a low of $2305.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $80101.0 (2024), against an average of $121385.2.
- Across the five-year window, Depreciation & Amortization (CF) plunged 68.59% in 2022 and jumped 1313.93% in 2023, its largest moves.
- SS Innovations International's Depreciation & Amortization (CF) stood at $24832.0 in 2022, then surged by 89.42% to $47037.0 in 2023, then surged by 210.24% to $145926.0 in 2024, then surged by 112.09% to $309491.0 in 2025, then grew by 4.61% to $323747.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $323747.0 (Q1 2026), $309491.0 (Q4 2025), and $297173.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 323,747.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 323,747.00 |
| Mar 31, 2026 | 323,747.00 |
| Dec 31, 2025 | 309,491.00 |
| Dec 31, 2025 | 309,491.00 |
| Sep 30, 2025 | 297,173.00 |
| Sep 30, 2025 | 297,173.00 |
| Jun 30, 2025 | 260,361.00 |
| Jun 30, 2025 | 260,361.00 |
| Mar 31, 2025 | 208,882.00 |
| Mar 31, 2025 | 208,882.00 |
| Dec 31, 2024 | 145,926.00 |
| Dec 31, 2024 | 145,926.00 |
| Sep 30, 2024 | 119,502.00 |
| Sep 30, 2024 | 119,502.00 |
| Jun 30, 2024 | 90,476.00 |
| Jun 30, 2024 | 90,476.00 |
| Mar 31, 2024 | 80,101.00 |
| Mar 31, 2024 | 80,101.00 |
| Dec 31, 2023 | 47,037.00 |
| Dec 31, 2023 | 47,037.00 |